JNJ Orthopedic Unit Sale Talks with Apollo Global Management Valued at $20B

Johnson & Johnson's DePuy Synthes orthopedic division is reportedly in talks to be acquired by Apollo Global Management for approximately $20 billion. This deal could be one of the largest mergers and acquisitions in the medical device industry. The divestment aligns with Johnson & Johnson's strategy to streamline its business portfolio, allowing it to focus on high-growth areas such as cardiovascular, surgical, and vision health sectors.

Johnson & Johnson has a market capitalization of around $640 billion and operates in the healthcare sector. The company previously announced plans to spin off DePuy Synthes into a standalone entity by October 2025. However, Apollo Global Management's acquisition talks could potentially change these plans.